Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.3K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

617
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
617
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Insights on Clinical Outcomes Using Integrated Shotgun Metagenomic Profiling of the Gut Microbiome, Resistome, and Host Immune-Inflammatory Response in Hospitalized Patients with Decompensated Cirrhosis.

Pathogens (Basel, Switzerland)·2026
Same author

Beyond traditional-the sick cirrhosis patient scores integrating cytokine and immune profiling for precision prognosis in hospitalized cirrhosis patients may help predict infection, ICU admission and long-term death post hospitalization.

Frontiers in medicine·2026
Same author

Durable Response with Single-Agent Pembrolizumab in a Patient with Metastatic Melanoma.

South Asian journal of cancer·2022
Same author

Visceral and renal protection in thoracoabdominal aortic surgery.

Indian journal of thoracic and cardiovascular surgery·2022
Same author

Improving the yield of diagnostic medical thoracoscopy for undiagnosed exudative pleural effusions using a rigid diagnostic algorithm.

International journal of mycobacteriology·2021
Same author

Perioperative right ventricular function and dysfunction in adult cardiac surgery-focused review (part 1-anatomy, pathophysiology, and diagnosis).

Indian journal of thoracic and cardiovascular surgery·2021

Related Experiment Video

Updated: Mar 17, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K

"Cryptic" mediastinal tuberculosis with myasthenia-thymoma complex.

George Jose Valooran1, Shiv Kumar Nair2, Krishnan Chandrasekharan1

  • 1Consultant, Department of Cardiovascular and Thoracic Surgery, Rajagiri Hospital, Chunangamvely, Aluva, Kochi, Kerala 683112, India.

The Indian Journal of Tuberculosis
|July 26, 2016
PubMed
Summary

Mediastinal tuberculosis is rare with myasthenia-thymoma complex, potentially worsened by immunosuppression. This combination presents a diagnostic challenge, requiring further research for optimal management strategies.

Keywords:
Anti-tubercular therapyInvasive thymomaMaximal thymectomyMyasthenia gravisTuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Related Experiment Videos

Last Updated: Mar 17, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

Area of Science:

  • Medical Science
  • Infectious Diseases
  • Oncology

Background:

  • Mediastinal tuberculosis is common in endemic regions but rarely co-occurs with myasthenia gravis and thymoma.
  • Immunosuppressive treatments for myasthenia-thymoma may heighten susceptibility to mediastinal tuberculosis.
  • Existing literature indicates a potential for worsening myasthenic symptoms when these conditions are combined.

Observation:

  • This case report highlights a rare instance of co-existing mediastinal tuberculosis and myasthenia-thymoma complex.
  • The patient's presentation involved mediastinal lymphadenopathy, initially diagnosed as invasive thymoma preoperatively.
  • The co-occurrence of these pathologies complicates surgical diagnosis and management.

Findings:

  • Mediastinal tuberculosis should be considered in patients with mediastinal lymphadenopathy and a history of or concurrent myasthenia-thymoma complex.
  • The interplay between immunosuppression, thymoma, and tuberculosis requires careful consideration.
  • Aggravation of myasthenic symptoms is a reported concern in such cases.

Implications:

  • This rare combination poses a diagnostic dilemma for surgeons.
  • Further research is needed to establish optimal management protocols, including timing for radiotherapy, immunosuppression weaning, and anti-tubercular therapy post-thymectomy.
  • Highlights the importance of considering mediastinal tuberculosis as a differential diagnosis in relevant clinical settings.